By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Medical Diagnostics and V&F Analyse- und Messtechnik announced Monday that they have formed an alliance based on mass spectrometry technology.

Unde the terms of the alliance, Oxford, UK-based OMD will offer and support V&F's high-performance mass spec analyzers in the UK and Ireland. In addition, OMD will establish a contract batch sample analysis service at its Oxford labs to provide analytical services to customers using V&F's instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.